EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma

[1] Cheon DJ(2014)A collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer Clin Cancer Res 20 711-723

[2] Tong Y(2014)A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development J Pathol 233 228-237

[3] Sim MS(2004)Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas Hum Pathol 35 663-669

[4] Dering J(2013)Altered expression of beta-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma Tumour Biol 34 2459-2468

[5] Berel D(2009)Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv Anat Pathol 16 267-282

[6] Cui X(2005)An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms Am J Surg Pathol 29 1034-1041

[7] Sherman-Baust CA(2007)Altered EphA5 mRNA expression in rat brain with a single methamphetamine treatment Neurosci Lett 424 116-121

[8] Kuhn E(2013)Analysis of EphA5 receptor in the developing rat brain: an in vivo study in congenital hypothyroidism model Eur J Pediatr 172 1077-1083

[9] Valle BL(2008)Changes in attack behavior and activity in EphA5 knockout mice Brain Res 1205 91-99

[10] Shih Ie M(2013)After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate Bone 57 343-354

[1] Cheon DJ(2014)A collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer Clin Cancer Res 20 711-723

[2] Tong Y(2014)A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development J Pathol 233 228-237

[3] Sim MS(2004)Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas Hum Pathol 35 663-669

[4] Dering J(2013)Altered expression of beta-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma Tumour Biol 34 2459-2468

[5] Berel D(2009)Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv Anat Pathol 16 267-282

[6] Cui X(2005)An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms Am J Surg Pathol 29 1034-1041

[7] Sherman-Baust CA(2007)Altered EphA5 mRNA expression in rat brain with a single methamphetamine treatment Neurosci Lett 424 116-121

[8] Kuhn E(2013)Analysis of EphA5 receptor in the developing rat brain: an in vivo study in congenital hypothyroidism model Eur J Pediatr 172 1077-1083

[9] Valle BL(2008)Changes in attack behavior and activity in EphA5 knockout mice Brain Res 1205 91-99

[10] Shih Ie M(2013)After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate Bone 57 343-354